Two more pharmaceutical companies, Abbvie and Genentech, to officially launch on TrumpRx
CBS News • • business
Key Points:
- Abbvie and Genentech will begin selling discounted medications on the White House's TrumpRx site, becoming the 10th and 11th pharmaceutical companies to participate.
- Abbvie will offer Humira, used for rheumatoid arthritis and other conditions, at an 86% discount, reducing the price from over $6,900 to $950 for uninsured patients.
- The discounted prices on TrumpRx are available only to uninsured individuals or those without insurance coverage for the drugs; insured patients typically pay lower prices through their plans.
- The administration aims to extend these discounts to government-insured patients through the proposed Great Healthcare Plan, though Congress has not yet acted on this proposal.
- Genentech will offer the flu treatment Xofluza at about $50, down from $168, and Amgen will add arthritis and psoriasis drugs Enbrel and Otezla to the TrumpRx offerings.
.png?format=webp&w=120&h=80)
